Identification ofrisk factors fortoxicity in patientswith hormonereceptor-positiveadvanced breastcancer treated withbevacizumab plusletrozole Daneng LiLinda McCallOlwen Hahn2018 год

Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study
статья из журнала